3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
CNS
1
Conditions
Breast Neoplasms
13
Motor Activity
12
Fatigue
6
Lymphedema
4
Depression
4
Neoplasms
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Head and Neck Neoplasms
3
Breast Cancer Lymphedema
3
Anxiety Disorders
3
Respiratory Aspiration
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Lung Neoplasms
2
Hypoventilation
2
Ventricular Dysfunction, Left
1
Uterine Cervical Neoplasms
1
Trismus
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Solid Tumor Cancer
1
Sarcoma
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Peripheral Nervous System Diseases
1
Pain
1
Osteosclerosis
1
Osteoarthritis, Knee
1
Interventions
Carboplatin
6
Pemetrexed
3
Paclitaxel
3
atezolizumab
2
Radiosurgery
2
Gemcitabine
2
Docetaxel
2
Cisplatin
2
pembrolizumab
1
durvalumab
1
cemiplimab
1
Vinorelbine
1
Tyrosine Kinase Inhibitors
1
Radiotherapy
1
Platinum Compounds
1
Nivolumab
1
Mediastinoscopy
1
Magnetic Resonance Spectroscopy
1
Interleukin-15
1
Fluticasone
1
Exercise Therapy
1
Etoposide
1
Dasatinib
1
Bronchoscopy
1
Blood Specimen Collection
1
Bevacizumab
1
Afatinib
1
Acetylcysteine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Bronchogenic
×
Exercise Therapy
×
Clear all
NCT04517019
2020-08-18
OnkoFit II
University Hospital Tuebingen
Phase NA
Unknown
201 enrolled